Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pandha

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Gene Therapy|May 7, 2010
Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?T Pencavel, R Seth, A Hayes, et al.
Current Pharmaceutical Biotechnology|July 12, 2011
Recent clinical experience with oncolytic virusesO G Donnelly, F Errington-Mais, R Prestwich, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 23, 2009
Indium-labelled autologous dendritic cells migrate to local lymph nodes after intratumoural injection in head and neck cancer patientsH Pandha, C D'Ambrosio, S Heenan, et al.
International Journal of Cancer|December 20, 1995
E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survivalK N Syrigos, T Krausz, J Waxman, et al.
Bone Marrow Transplantation|March 14, 2000
The role of autologous transplantation in patients with multiple myeloma aged 65 years and overB Sirohi, R Powles, J Treleaven, et al.
British Journal of Cancer|April 7, 2005
Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell primingA Merrick, F Errington, K Milward, et al.
British Journal of Cancer|March 5, 2004
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancersJ B Bartlett, A Michael, I A Clarke, et al.
Clinical and Experimental Immunology|March 25, 2014
Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancerN E Annels, G R Simpson, M Denyer, et al.
Gene Therapy|October 26, 2016
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapyE Ilett, T Kottke, J Thompson, et al.
International Journal of Cancer|August 29, 2013
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascitesV A Jennings, E J Ilett, K J Scott, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Gene Therapy|May 7, 2010
Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?T Pencavel, R Seth, A Hayes, et al.
Current Pharmaceutical Biotechnology|July 12, 2011
Recent clinical experience with oncolytic virusesO G Donnelly, F Errington-Mais, R Prestwich, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 23, 2009
Indium-labelled autologous dendritic cells migrate to local lymph nodes after intratumoural injection in head and neck cancer patientsH Pandha, C D'Ambrosio, S Heenan, et al.
International Journal of Cancer|December 20, 1995
E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survivalK N Syrigos, T Krausz, J Waxman, et al.
Bone Marrow Transplantation|March 14, 2000
The role of autologous transplantation in patients with multiple myeloma aged 65 years and overB Sirohi, R Powles, J Treleaven, et al.
British Journal of Cancer|April 7, 2005
Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell primingA Merrick, F Errington, K Milward, et al.
British Journal of Cancer|March 5, 2004
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancersJ B Bartlett, A Michael, I A Clarke, et al.
Clinical and Experimental Immunology|March 25, 2014
Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancerN E Annels, G R Simpson, M Denyer, et al.
Gene Therapy|October 26, 2016
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapyE Ilett, T Kottke, J Thompson, et al.
International Journal of Cancer|August 29, 2013
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascitesV A Jennings, E J Ilett, K J Scott, et al.
Pageof 4